Posted 9/11/2018 8:00 PM (GMT 0)
Always exciting to have more options available on the horizon for those who fail current treatments. Early on, so I hope it survives the clinical trial vetting process (some do, some do not). I tried reading up on what ABX464 does, but am a bit perplexed how that helps UC patients. Anybody got any better sources that are easier to understand for its affect on UC?